ALZN — Alzamend Neuro Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Alzamend Neuro, fiscal year end - April 30th, USD millions except per share, conversion factor applied.

	2020 April 30th	2021 April 30th	2022 April 30th	2023 April 30th	2024 April 30th
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.09	1.93	14.1	5.14	0.376
Net Total Accounts Receivable
Net Total Receivables	0.194	0.016	0	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.81	2.91	14.4	5.84	0.455
Net Property, Plant And Equipment	—	—	0.103	0.08	0.176
Total Assets	1.81	2.91	14.5	5.92	0.632
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.992	0.9	1.16	2.87	3.23
Total Long Term Debt
Total Debt
Total Liabilities	0.992	0.9	1.16	2.87	3.23
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.822	2.01	13.4	3.05	-2.59
Total Liabilities & Shareholders' Equity	1.81	2.91	14.5	5.92	0.632
Total Common Shares Outstanding
Total Preferred Shares Outstanding